BACKGROUND: Severe hyperbilirubinemia is toxic during central nervous system development. Prolonged and uncontrolled high levels of unconjugated bilirubin lead to bilirubin-induced neurological damage and eventually death by kernicterus. Bilirubin neurotoxicity is characterized by a wide array of neurological deficits, including irreversible abnormalities in motor, sensitive and cognitive functions, due to bilirubin accumulation in the brain. Despite the abundant literature documenting the in vitro and in vivo toxic effects of bilirubin, it is unclear which molecular and cellular events actually characterize bilirubin-induced neurodegeneration in vivo. METHODS: We used a mouse model of neonatal hyperbilirubinemia to temporally and spatially define the response of the developing cerebellum to the bilirubin insult. RESULTS: We showed that the exposure of developing cerebellum to sustained bilirubin levels induces the activation of oxidative stress, ER stress and inflammatory markers at the early stages of the disease onset. In particular, we identified TNFα and NFKβ as key mediators of bilirubin-induced inflammatory response. Moreover, we reported that M1 type microglia is increasingly activated during disease progression. Failure to counteract this overwhelming stress condition resulted in the induction of the apoptotic pathway and the generation of the glial scar. Finally, bilirubin induced the autophagy pathway in the stages preceding death of the animals. CONCLUSIONS: This study demonstrates that inflammation is a key contributor to bilirubin damage that cooperates with ER stress in the onset of neurotoxicity. Pharmacological modulation of the inflammatory pathway may be a potential intervention target to ameliorate neonatal lethality in Ugt1 -/- mice.

4th Department of Internal Medicine 1st Faculty of Medicine Charles University 120 00 Prague Czech Republic

Institute of Medical Biochemistry and Laboratory Medicine 1st Faculty of Medicine Charles University 120 00 Prague Czech Republic

International Centre for Genetic Engineering and Biotechnology Padriciano 99 34149 Trieste Italy

Zobrazit více v PubMed

Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. 2002;140:396–403. doi: 10.1067/mpd.2002.123098. PubMed DOI

Pediatrics AAo Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316. doi: 10.1542/peds.114.1.297. PubMed DOI

Reichman NE, Teitler JO, Moullin S, Ostfeld BM, Hegyi T. Late-preterm birth and neonatal morbidities: population-level and within-family estimates. Ann Epidemiol. 2015;25:126–132. doi: 10.1016/j.annepidem.2014.10.016. PubMed DOI

Bhutani VK, Wong RJ. Bilirubin neurotoxicity in preterm infants: risk and prevention. J Clin Neonatol. 2013;2:61–69. doi: 10.4103/2249-4847.116402. PubMed DOI PMC

Greco C, Arnolda G, Boo NY, Iskander IF, Okolo AA, Rohsiswatmo R, Shapiro SM, Watchko J, Wennberg RP, Tiribelli C, Coda Zabetta CD. Neonatal jaundice in Low- and middle-income countries: lessons and future directions from the 2015 don ostrow trieste yellow retreat. Neonatology. 2016;110:172–180. doi: 10.1159/000445708. PubMed DOI

Watchko JF. Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. Neuromolecular Med. 2006;8:513–529. doi: 10.1385/NMM:8:4:513. PubMed DOI

Olusanya BO, Ogunlesi TA, Slusher TM. Why is kernicterus still a major cause of death and disability in low-income and middle-income countries? Arch Dis Child. 2014;99:1117–1121. doi: 10.1136/archdischild-2013-305506. PubMed DOI

Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage—mechanisms and management approaches. N Engl J Med. 2013;369:2021–2030. doi: 10.1056/NEJMra1308124. PubMed DOI

Schreuder AB, Rice AC, Vanikova J, Vitek L, Shapiro SM, Verkade HJ. Albumin administration protects against bilirubin-induced auditory brainstem dysfunction in Gunn rat pups. Liver Int. 2013;33:1557–1565. PubMed

Vodret S, Bortolussi G, Schreuder AB, Jasprova J, Vitek L, Verkade HJ, Muro AF. Albumin administration prevents neurological damage and death in a mouse model of severe neonatal hyperbilirubinemia. Sci Rep. 2015;5:16203. doi: 10.1038/srep16203. PubMed DOI PMC

Falcao AS, Bellarosa C, Fernandes A, Brito MA, Silva RF, Tiribelli C, Brites D. Role of multidrug resistance-associated protein 1 expression in the in vitro susceptibility of rat nerve cell to unconjugated bilirubin. Neuroscience. 2007;144:878–888. doi: 10.1016/j.neuroscience.2006.10.026. PubMed DOI

Falcao AS, Fernandes A, Brito MA, Silva RF, Brites D. Bilirubin-induced immunostimulant effects and toxicity vary with neural cell type and maturation state. Acta Neuropathol. 2006;112:95–105. doi: 10.1007/s00401-006-0078-4. PubMed DOI

Notter MF, Kendig JW. Differential sensitivity of neural cells to bilirubin toxicity. Exp Neurol. 1986;94:670–682. doi: 10.1016/0014-4886(86)90246-3. PubMed DOI

Silva RF, Rodrigues CM, Brites D. Rat cultured neuronal and glial cells respond differently to toxicity of unconjugated bilirubin. Pediatr Res. 2002;51:535–541. doi: 10.1203/00006450-200204000-00022. PubMed DOI

Vaz AR, Silva SL, Barateiro A, Falcao AS, Fernandes A, Brito MA, Brites D. Selective vulnerability of rat brain regions to unconjugated bilirubin. Mol Cell Neurosci. 2011;48:82–93. doi: 10.1016/j.mcn.2011.06.008. PubMed DOI

Bortolussi G, Zentilin L, Baj G, Giraudi P, Bellarosa C, Giacca M, Tiribelli C, Muro AF. Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer. FASEB J. 2012;26:1052–1063. doi: 10.1096/fj.11-195461. PubMed DOI PMC

Bortolussi G, Baj G, Vodret S, Viviani G, Bittolo T, Muro AF. Age-dependent pattern of cerebellar susceptibility to bilirubin neurotoxicity in vivo in mice. Dis Model Mech. 2014;7:1057–1068. doi: 10.1242/dmm.016535. PubMed DOI PMC

Bortolussi G, Codarin E, Antoniali G, Vascotto C, Vodret S, Arena S, Cesaratto L, Scaloni A, Tell G, Muro AF. Impairment of enzymatic antioxidant defenses is associated with bilirubin-induced neuronal cell death in the cerebellum of Ugt1 KO mice. Cell Death Dis. 2015;6 doi: 10.1038/cddis.2015.113. PubMed DOI PMC

Brito MA, Brites D, Butterfield DA. A link between hyperbilirubinemia, oxidative stress and injury to neocortical synaptosomes. Brain Res. 2004;1026:33–43. doi: 10.1016/j.brainres.2004.07.063. PubMed DOI

Oakes GH, Bend JR. Global changes in gene regulation demonstrate that unconjugated bilirubin is able to upregulate and activate select components of the endoplasmic reticulum stress response pathway. J Biochem Mol Toxicol. 2010;24:73–88. PubMed

Oakes GH, Bend JR. Early steps in bilirubin-mediated apoptosis in murine hepatoma (Hepa 1c1c7) cells are characterized by aryl hydrocarbon receptor-independent oxidative stress and activation of the mitochondrial pathway. J Biochem Mol Toxicol. 2005;19:244–255. doi: 10.1002/jbt.20086. PubMed DOI

Fernandes A, Falcao AS, Silva RF, Gordo AC, Gama MJ, Brito MA, Brites D. Inflammatory signalling pathways involved in astroglial activation by unconjugated bilirubin. J Neurochem. 2006;96:1667–1679. doi: 10.1111/j.1471-4159.2006.03680.x. PubMed DOI

Fernandes A, Falcao AS, Silva RF, Brito MA, Brites D. MAPKs are key players in mediating cytokine release and cell death induced by unconjugated bilirubin in cultured rat cortical astrocytes. Eur J Neurosci. 2007;25:1058–1068. doi: 10.1111/j.1460-9568.2007.05340.x. PubMed DOI

Lin S, Wei X, Bales KR, Paul AB, Ma Z, Yan G, Paul SM, Du Y. Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia-induced cerebellar hypoplasia in the Gunn rat. Eur J Neurosci. 2005;22:21–27. doi: 10.1111/j.1460-9568.2005.04182.x. PubMed DOI

Lin S, Yan C, Wei X, Paul SM, Du Y. p38 MAP kinase mediates bilirubin-induced neuronal death of cultured rat cerebellar granule neurons. Neurosci Lett. 2003;353:209–212. doi: 10.1016/j.neulet.2003.09.053. PubMed DOI

Yueh MF, Chen S, Nguyen N, Tukey RH. Developmental onset of bilirubin-induced neurotoxicity involves Toll-like receptor 2-dependent signaling in humanized UDP-glucuronosyltransferase1 mice. J Biol Chem. 2014;289:4699–4709. doi: 10.1074/jbc.M113.518613. PubMed DOI PMC

Bockor L, Bortolussi G, Vodret S, Iaconcig A, Jasprova J, Zelenka J, Vitek L, Tiribelli C, Muro AF. Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1-/- lethal mouse model of neonatal hyperbilirubinemia. Hum Mol Genet. 2016. PubMed

Schutta HS, Johnson L. Bilirubin encephalopathy in the Gunn rat: a fine structure study of the cerebellar cortex. J Neuropathol Exp Neurol. 1967;26:377–396. doi: 10.1097/00005072-196707000-00003. PubMed DOI

Fujiwara R, Nguyen N, Chen S, Tukey RH. Developmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus. Proc Natl Acad Sci U S A. 2010;107:5024–5029. doi: 10.1073/pnas.0913290107. PubMed DOI PMC

Whitney ER, Kemper TL, Rosene DL, Bauman ML, Blatt GJ. Calbindin-D28k is a more reliable marker of human Purkinje cells than standard Nissl stains: a stereological experiment. J Neurosci Methods. 2008;168:42–47. doi: 10.1016/j.jneumeth.2007.09.009. PubMed DOI

Sarnat HB, Nochlin D, Born DE. Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in early human fetal nervous system. Brain Dev. 1998;20:88–94. doi: 10.1016/S0387-7604(97)00111-3. PubMed DOI

Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140:918–934. doi: 10.1016/j.cell.2010.02.016. PubMed DOI PMC

Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease—a double-edged sword. Neuron. 2002;35:419–432. doi: 10.1016/S0896-6273(02)00794-8. PubMed DOI

Barateiro A, Vaz AR, Silva SL, Fernandes A, Brites D. ER stress, mitochondrial dysfunction and calpain/JNK activation are involved in oligodendrocyte precursor cell death by unconjugated bilirubin. Neuromolecular Med. 2012;14:285–302. doi: 10.1007/s12017-012-8187-9. PubMed DOI

Calligaris R, Bellarosa C, Foti R, Roncaglia P, Giraudi P, Krmac H, Tiribelli C, Gustincich S. A transcriptome analysis identifies molecular effectors of unconjugated bilirubin in human neuroblastoma SH-SY5Y cells. BMC Genomics. 2009;10:543. doi: 10.1186/1471-2164-10-543. PubMed DOI PMC

Qaisiya M, Brischetto C, Jasprova J, Vitek L, Tiribelli C, Bellarosa C. Bilirubin-induced ER stress contributes to the inflammatory response and apoptosis in neuronal cells. Arch Toxicol. 2016. PubMed

Brito MA, Lima S, Fernandes A, Falcao AS, Silva RF, Butterfield DA, Brites D. Bilirubin injury to neurons: contribution of oxidative stress and rescue by glycoursodeoxycholic acid. Neurotoxicology. 2008;29:259–269. doi: 10.1016/j.neuro.2007.11.002. PubMed DOI

Brito MA, Rosa AI, Falcao AS, Fernandes A, Silva RF, Butterfield DA, Brites D. Unconjugated bilirubin differentially affects the redox status of neuronal and astroglial cells. Neurobiol Dis. 2008;29:30–40. doi: 10.1016/j.nbd.2007.07.023. PubMed DOI

Fischer R, Maier O. Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxid Med Cell Longev. 2015;2015:610813. doi: 10.1155/2015/610813. PubMed DOI PMC

Giraudi PJ, Bellarosa C, Coda-Zabetta CD, Peruzzo P, Tiribelli C. Functional induction of the cystine-glutamate exchanger system Xc(-) activity in SH-SY5Y cells by unconjugated bilirubin. PLoS One. 2011;6 doi: 10.1371/journal.pone.0029078. PubMed DOI PMC

Rodrigues CM, Sola S, Silva R, Brites D. Bilirubin and amyloid-beta peptide induce cytochrome c release through mitochondrial membrane permeabilization. Mol Med. 2000;6:936–946. PubMed PMC

Stoeckius M, Erat A, Fujikawa T, Hiromura M, Koulova A, Otterbein L, Bianchi C, Tobiasch E, Dagon Y, Sellke FW, Usheva A. Essential roles of Raf/extracellular signal-regulated kinase/mitogen-activated protein kinase pathway, YY1, and Ca2+ influx in growth arrest of human vascular smooth muscle cells by bilirubin. J Biol Chem. 2012;287:15418–15426. doi: 10.1074/jbc.M111.266510. PubMed DOI PMC

Brites D. Bilirubin injury to neurons and glial cells: new players, novel targets, and newer insights. Semin Perinatol. 2011;35:114–120. doi: 10.1053/j.semperi.2011.02.004. PubMed DOI

Tell G, Gustincich S. Redox state, oxidative stress, and molecular mechanisms of protective and toxic effects of bilirubin on cells. Curr Pharm Des. 2009;15:2908–2914. doi: 10.2174/138161209789058174. PubMed DOI

Qaisiya M, Coda Zabetta CD, Bellarosa C, Tiribelli C. Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway. Cell Signal. 2014;26:512–520. doi: 10.1016/j.cellsig.2013.11.029. PubMed DOI

Daood MJ, Hoyson M, Watchko JF. Lipid peroxidation is not the primary mechanism of bilirubin-induced neurologic dysfunction in jaundiced Gunn rat pups. Pediatr Res. 2012;72:455–459. doi: 10.1038/pr.2012.111. PubMed DOI

Gazzin S, Zelenka J, Zdrahalova L, Konickova R, Zabetta CC, Giraudi PJ, Berengeno AL, Raseni A, Robert MC, Vitek L, Tiribelli C. Bilirubin accumulation and Cyp mRNA expression in selected brain regions of jaundiced Gunn rat pups. Pediatr Res. 2012;71:653–660. doi: 10.1038/pr.2012.23. PubMed DOI

Silva SL, Vaz AR, Diogenes MJ, van Rooijen N, Sebastiao AM, Fernandes A, Silva RF, Brites D. Neuritic growth impairment and cell death by unconjugated bilirubin is mediated by NO and glutamate, modulated by microglia, and prevented by glycoursodeoxycholic acid and interleukin-10. Neuropharmacology. 2012;62:2398–2408. doi: 10.1016/j.neuropharm.2012.02.002. PubMed DOI

Kim KH, Jeong JY, Surh YJ, Kim KW. Expression of stress-response ATF3 is mediated by Nrf2 in astrocytes. Nucleic Acids Res. 2010;38:48–59. doi: 10.1093/nar/gkp865. PubMed DOI PMC

Chaudhari N, Talwar P, Parimisetty A, Lefebvre d'Hellencourt C, Ravanan P. A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress. Front Cell Neurosci. 2014;8:213. doi: 10.3389/fncel.2014.00213. PubMed DOI PMC

Falcao AS, Silva RF, Pancadas S, Fernandes A, Brito MA, Brites D. Apoptosis and impairment of neurite network by short exposure of immature rat cortical neurons to unconjugated bilirubin increase with cell differentiation and are additionally enhanced by an inflammatory stimulus. J Neurosci Res. 2007;85:1229–1239. doi: 10.1002/jnr.21227. PubMed DOI

Fernandes A, Falcao AS, Abranches E, Bekman E, Henrique D, Lanier LM, Brites D. Bilirubin as a determinant for altered neurogenesis, neuritogenesis, and synaptogenesis. Dev Neurobiol. 2009;69:568–582. doi: 10.1002/dneu.20727. PubMed DOI PMC

Olmos G, Llado J. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators Inflamm. 2014;2014:861231. doi: 10.1155/2014/861231. PubMed DOI PMC

Fernandes A, Silva RF, Falcao AS, Brito MA, Brites D. Cytokine production, glutamate release and cell death in rat cultured astrocytes treated with unconjugated bilirubin and LPS. J Neuroimmunol. 2004;153:64–75. doi: 10.1016/j.jneuroim.2004.04.007. PubMed DOI

Gordo AC, Falcao AS, Fernandes A, Brito MA, Silva RF, Brites D. Unconjugated bilirubin activates and damages microglia. J Neurosci Res. 2006;84:194–201. doi: 10.1002/jnr.20857. PubMed DOI

Fernandes A, Brites D. Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents. Curr Pharm Des. 2009;15:2915–2926. doi: 10.2174/138161209789058165. PubMed DOI

Brites D. The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation. Front Pharmacol. 2012;3:88. doi: 10.3389/fphar.2012.00088. PubMed DOI PMC

Mikoshiba K, Kohsaka S, Takamatsu K, Tsukada Y. Cerebellar hypoplasia in the Gunn rat with hereditary hyperbilirubinemia: immunohistochemical and neurochemical studies. J Neurochem. 1980;35:1309–1318. doi: 10.1111/j.1471-4159.1980.tb09003.x. PubMed DOI

Barateiro A, Chen S, Yueh MF, Fernandes A, Domingues HS, Relvas J, Barbier O, Nguyen N, Tukey RH, Brites D. Reduced myelination and increased glia reactivity resulting from severe neonatal hyperbilirubinemia. Mol Pharmacol. 2016;89:84–93. doi: 10.1124/mol.115.098228. PubMed DOI PMC

Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29:13435–13444. doi: 10.1523/JNEUROSCI.3257-09.2009. PubMed DOI PMC

Hsieh CL, Kim CC, Ryba BE, Niemi EC, Bando JK, Locksley RM, Liu J, Nakamura MC, Seaman WE. Traumatic brain injury induces macrophage subsets in the brain. Eur J Immunol. 2013;43:2010–2022. doi: 10.1002/eji.201243084. PubMed DOI PMC

Turtzo LC, Lescher J, Janes L, Dean DD, Budde MD, Frank JA. Macrophagic and microglial responses after focal traumatic brain injury in the female rat. J Neuroinflammation. 2014;11:82. doi: 10.1186/1742-2094-11-82. PubMed DOI PMC

Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112:24–49. doi: 10.1016/j.pneurobio.2013.10.004. PubMed DOI

Alirezaei M, Kemball CC, Whitton JL. Autophagy, inflammation and neurodegenerative disease. Eur J Neurosci. 2011;33:197–204. doi: 10.1111/j.1460-9568.2010.07500.x. PubMed DOI PMC

Palmela I, Sasaki H, Cardoso FL, Moutinho M, Kim KS, Brites D, Brito MA. Time-dependent dual effects of high levels of unconjugated bilirubin on the human blood-brain barrier lining. Front Cell Neurosci. 2012;6:22. doi: 10.3389/fncel.2012.00022. PubMed DOI PMC

Zhang Y, Wu Y, Cheng Y, Zhao Z, Tashiro S, Onodera S, Ikejima T. Fas-mediated autophagy requires JNK activation in HeLa cells. Biochem Biophys Res Commun. 2008;377:1205–1210. doi: 10.1016/j.bbrc.2008.10.151. PubMed DOI

B'Chir W, Maurin AC, Carraro V, Averous J, Jousse C, Muranishi Y, Parry L, Stepien G, Fafournoux P, Bruhat A. The eIF2alpha/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res. 2013;41:7683–7699. doi: 10.1093/nar/gkt563. PubMed DOI PMC

Inden M, Kitamura Y, Takeuchi H, Yanagida T, Takata K, Kobayashi Y, Taniguchi T, Yoshimoto K, Kaneko M, Okuma Y, et al. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J Neurochem. 2007;101:1491–1504. doi: 10.1111/j.1471-4159.2006.04440.x. PubMed DOI

Kim HS, Suh YH. Minocycline and neurodegenerative diseases. Behav Brain Res. 2009;196:168–179. doi: 10.1016/j.bbr.2008.09.040. PubMed DOI

Geiger AS, Rice AC, Shapiro SM. Minocycline blocks acute bilirubin-induced neurological dysfunction in jaundiced Gunn rats. Neonatology. 2007;92:219–226. doi: 10.1159/000103740. PubMed DOI

Rice AC, Chiou VL, Zuckoff SB, Shapiro SM. Profile of minocycline neuroprotection in bilirubin-induced auditory system dysfunction. Brain Res. 2011;1368:290–298. doi: 10.1016/j.brainres.2010.10.052. PubMed DOI PMC

The Role of Bilirubin and the Other "Yellow Players" in Neurodegenerative Diseases